WHO Recommends Antiretroviral Drug Dolutegravir As Preferred HIV Treatment, Including For Women Of Childbearing Age, Pregnant Women

U.N. News: U.N. health agency ‘strongly recommends’ dolutegravir antiretroviral medication to manage HIV
“Based on new evidence, the United Nations health agency on Monday announced it was recommending the use of the antiretroviral drug dolutegravir (DTG) — which, with other medication, treats HIV/AIDS — as the preferred first- and second-line treatment for all cases, including pregnant women and those who have the potential to give birth…” (6/22).

Additional coverage of the new recommendation is available from MedPage Today and The Telegraph.